BlackRock has cleared its Q2 earnings hurdle with a jump of 6.6% on July 15, and the stock now trades at $1,093 — well above where it stood when either of the two previous preview articles were written.
The price action since the print has been decisive. BLK gained 10.4% on the week, sharply outpacing correlated peers: IVZ rose 4.9%, APAM added 6.5%, and BX gained 3%. The lending market remains entirely unbothered — borrow availability is effectively unconstrained, and short interest holds at just 1.35% of free float. That level has barely moved, rising only 3% over the past month. There is no short-side pressure, no squeeze dynamic, and no signal that bears are building conviction against the move.
The analyst picture has one notable wrinkle. Morgan Stanley's Mike Cyprys trimmed his target from $1,430 to $1,383 on July 14 — a modest cut, but telling given he was among the most bullish voices heading into the print. The broader consensus remains firmly constructive: the mean target now sits at $1,281, implying roughly 17% upside from current levels. Barclays, Evercore ISI, and Keefe Bruyette all raised targets ahead of results and have not reversed course. The options market has also shifted since the pre-earnings setup — the put/call ratio edged back up to 1.00, roughly in line with its 20-day average of 1.02, suggesting options traders have moved from call-heavy positioning to a more neutral stance now that the event risk has passed.
Bulls point to AUM near $13.5 trillion, organic base fee growth running ahead of BlackRock's own 2030 targets, and the HPS contribution still ahead as a fee-rate catalyst. Bears flag rising G&A costs, operating margin guidance that has been revised down, and the reality that the Q2 beat was solid rather than spectacular — enough to validate the thesis, not enough to close the gap to the most aggressive price targets. The EPS forward growth factor ranks in the 94th percentile, so the earnings trajectory is well understood and largely priced in.
The print itself is now public record. What the next few sessions will test is whether $1,093 — a level the stock reached only after a 10% weekly rally — is where the Street's constructive consensus and BLK's fundamental growth story meet, or whether the Morgan Stanley target trim is the first signal that the easy upside has already been captured.
See the live data behind this article on ORTEX.
Open BLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
